SEC Filing | Colgate-Palmolive Company

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ramundo Katherine H

(Last)

(First)

(Middle)

COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK

10025

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/13/2011

3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
VP Dep Gen Counsel & Asst Sec

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8,975	D
Common Stock	8,113	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	09/07/2009⁽¹⁾	09/07/2012	Common Stock	5,200	60.68	D
Stock Option (Right to Buy)	09/12/2010⁽¹⁾	09/12/2013	Common Stock	6,500	68.15	D
Stock Option (Right to Buy)	09/11/2009⁽²⁾	09/11/2014	Common Stock	8,200	79.52	D
Stock Option (Right to Buy)	09/10/2010⁽²⁾	09/10/2015	Common Stock	8,200	73.23	D
Stock Option (Right to Buy)	09/16/2011⁽²⁾	09/09/2016	Common Stock	12,000	76.58	D

Explanation of Responses:

1. Option became 100% exercisable on the date shown in this column.

2. Option becomes exercisable in one-third increments on each anniversary date, with the first third becoming exercisable on the date shown in this column.

Remarks:

	Nina R. Huffman by Power of Attorney	01/20/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.


POWER OF ATTORNEY

FORMS 3, 4 AND 5

I, Katherine Hargrove Ramundo, an officer of Colgate-Palmolive Company
(the "Company"), do hereby appoint Andrew D. Hendry, Nina Huffman,
Joyce McCarthy, Kristine Hutchinson and J.Thomas Yust, severally,
as my true and lawful attorneys with the power to execute and file on
my behalf and in my place and stead,as I myself could do if I were
personally present,any Form 3, 4 or 5, and any, or all, amendments thereto,
to be filed by me pursuant to Section 16(a) of the Securities Exchange Act
of 1934 in connection with my ownership, either directly or indirectly, or
any change therein, of securities of the Company.

This Power of Attorney shall remain in force and effect for
as long as I continue to be an officer of the Company or until earlier
revoked by me in writing and shall not otherwise be affected by my
subsequent disability or incompetence.

In witness whereof, I have signed this instrument
on January 20, 2011.



Signature:  /s/ Katherine Hargrove Ramundo
Print Name:   Katherine Hargrove Ramundo